Allurion Closes Offering and Private Placement to Advance GLP-1 Pipeline Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, announced the successful closing of its previously announced registered…
OS Therapies Granted Patent for OST-HER2 Commercial Manufacturing OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company focused on immunotherapies and targeted drug conjugates for cancer treatment, announced today that…
Stablepharma Secures €2.5M EIC Grant, Among Top 71 EU Innovators UK biotech Stablepharma Ltd has secured a €2.5M grant from the European Innovation Council (EIC) Accelerator Programme. The funding acknowledges…
Stablepharma Secures €2.5M EIC Grant, Named Top EU Innovator UK-based biotechnology firm Stablepharma Ltd has been awarded €2.5 million through the prestigious European Innovation Council (EIC) Accelerator program. The grant…
Arcus Biosciences Retains Casdatifan Rights and Announces $150M Stock Offering Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage global biopharmaceutical company specializing in cancer treatments, announced today that Gilead’s exclusive option rights…
Pneuma Respiratory Enhances Inhaled Therapies for Better Respiratory Health Pneuma Respiratory, a leading med-tech and pharmaceutical company, is pioneering innovative solutions in inhaled respiratory therapeutics aimed at transforming respiratory care.…
InnoCare Announces Phase III Study Approval of ICP-248 and Orelabrutinib for CLL/SLL in China InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focused on developing therapies for cancer…
BioIntelliSense Teams Up with Hicuity Health for Scalable Continuous Patient Monitoring BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, has announced a strategic partnership with Hicuity Health, a…
LimmaTech Begins Phase 1 Trial of Staphylococcus aureus Vaccine LBT-SA7 LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced the vaccination of the first…
Innate Pharma’s Lacutamab Receives FDA Breakthrough Therapy Designation for Sézary Syndrome Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) has announced that the U.S. Food and Drug Administration (FDA) has…
Five-Year Sotyktu (Deucravacitinib) Data Show Consistent Safety and Durable Response in Psoriasis Bristol Myers Squibb (NYSE:BMY) has announced new five-year data from the POETYK PSO long-term extension (LTE) trial, evaluating…
CSL and Arcturus’ KOSTAIVE® Self-amplifying mRNA COVID-19 Vaccine Approved by European Commission CSL (ASX: CSL; USOTC: CSLLY), a global biotechnology leader, and Arcturus Therapeutics (Nasdaq: ARCT), a pioneer in self-amplifying…